We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug


Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
read more

Source: NY Times


12:45, March 8, 2024 Pam Belluck

News